Jurre A. Den Haan

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.

Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.

Journal: Acta neuropathologica

Published: January 30, 2024

Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions.

Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: August 07, 2023

TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration.

TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration.

Journal: Acta neuropathologica

Published: May 10, 2023

α-Synuclein pathology in post-mortem retina and optic nerve is specific for α-synucleinopathies.

α-Synuclein pathology in post-mortem retina and optic nerve is specific for α-synucleinopathies.

Journal: NPJ Parkinson's disease

Published: March 23, 2023

Correction to: Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.

Correction to: Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.

Journal: Acta neuropathologica

Published: December 23, 2022

Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.

Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.

Journal: Acta neuropathologica

Published: June 03, 2022

No difference in retinal fluorescence after oral curcumin intake in amyloid-proven AD cases compared to controls.

No difference in retinal fluorescence after oral curcumin intake in amyloid-proven AD cases compared to controls.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: September 21, 2021

Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances.

Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances.

Journal: Progress in retinal and eye research

Published: July 04, 2020

Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward.

Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 02, 2019

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: June 29, 2019

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: June 14, 2019

Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease.

Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease.

Journal: Alzheimer's research & therapy

Published: December 21, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026